JP2013507443A - 薬学的組成物 - Google Patents

薬学的組成物 Download PDF

Info

Publication number
JP2013507443A
JP2013507443A JP2012534277A JP2012534277A JP2013507443A JP 2013507443 A JP2013507443 A JP 2013507443A JP 2012534277 A JP2012534277 A JP 2012534277A JP 2012534277 A JP2012534277 A JP 2012534277A JP 2013507443 A JP2013507443 A JP 2013507443A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
composition according
acid
microbial infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012534277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507443A5 (enExample
Inventor
エリック エス． ブラック，
ダンピン リ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melinta Subsidiary Corp
Original Assignee
Rib X Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rib X Pharmaceuticals Inc filed Critical Rib X Pharmaceuticals Inc
Publication of JP2013507443A publication Critical patent/JP2013507443A/ja
Publication of JP2013507443A5 publication Critical patent/JP2013507443A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012534277A 2009-10-13 2010-10-12 薬学的組成物 Pending JP2013507443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25102309P 2009-10-13 2009-10-13
US61/251,023 2009-10-13
PCT/US2010/052263 WO2011046905A2 (en) 2009-10-13 2010-10-12 Pharmaceutical compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015113698A Division JP2015155479A (ja) 2009-10-13 2015-06-04 薬学的組成物

Publications (2)

Publication Number Publication Date
JP2013507443A true JP2013507443A (ja) 2013-03-04
JP2013507443A5 JP2013507443A5 (enExample) 2013-11-07

Family

ID=43876821

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012534277A Pending JP2013507443A (ja) 2009-10-13 2010-10-12 薬学的組成物
JP2015113698A Pending JP2015155479A (ja) 2009-10-13 2015-06-04 薬学的組成物
JP2017078885A Withdrawn JP2017141285A (ja) 2009-10-13 2017-04-12 薬学的組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015113698A Pending JP2015155479A (ja) 2009-10-13 2015-06-04 薬学的組成物
JP2017078885A Withdrawn JP2017141285A (ja) 2009-10-13 2017-04-12 薬学的組成物

Country Status (16)

Country Link
US (2) US20120208857A1 (enExample)
EP (2) EP2488175A4 (enExample)
JP (3) JP2013507443A (enExample)
KR (1) KR101791709B1 (enExample)
CN (1) CN102573840A (enExample)
AU (2) AU2010307054A1 (enExample)
BR (1) BR112012008649A2 (enExample)
CA (1) CA2776310A1 (enExample)
EA (1) EA022765B1 (enExample)
IL (1) IL219018A (enExample)
MX (1) MX337145B (enExample)
NZ (1) NZ599151A (enExample)
PH (1) PH12012500695A1 (enExample)
SG (1) SG10201406571YA (enExample)
UA (1) UA111145C2 (enExample)
WO (1) WO2011046905A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027791B1 (ru) * 2010-11-24 2017-09-29 Мелинта Терапьютикс, Инк. Фармацевтические композиции
CN104784113B (zh) * 2015-04-30 2017-09-29 成都国为生物医药有限公司 一种含有利奈唑胺的组合物及其制备方法
US11112370B2 (en) * 2019-01-04 2021-09-07 The Boeing Company Reconfigurable backscatter detector

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527207A (ja) * 2000-03-22 2003-09-16 ファルマシア・アンド・アップジョン・カンパニー リネゾリド静脈内溶液用容器
JP2004506699A (ja) * 2000-08-22 2004-03-04 ファルマシア・コーポレーション 薬物負荷を強化したオキサゾリジノン抗生物質薬の溶液組成物
JP2007514737A (ja) * 2003-12-18 2007-06-07 ドン・ア・ファーム・カンパニー・リミテッド 新規オキサゾリジノン誘導体
WO2008127300A2 (en) * 2006-10-23 2008-10-23 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
PE20011088A1 (es) * 2000-03-22 2001-10-04 Upjohn Co Tratamiento de infecciones del tracto urinario con oxazolidinonas antibacterianas
HUP0301562A2 (hu) 2000-06-05 2003-12-29 Dong A Pharm. Co., Ltd. Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények
CN1713924A (zh) * 2000-08-22 2005-12-28 法马西亚公司 药物含量增加的噁唑烷酮抗菌药物溶液组合物
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
CN101429170B (zh) * 2003-06-03 2015-05-13 梅林塔医疗有限公司 联芳基杂环化合物的制备和用途
JP5043428B2 (ja) * 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
WO2005061468A1 (en) 2003-12-17 2005-07-07 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US7696211B2 (en) * 2005-04-29 2010-04-13 Wilson Constance N Methods and pharmaceutical compositions for treating sepsis
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
WO2007086011A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefepime, tazobactam and linezolid
WO2007133803A2 (en) * 2006-05-15 2007-11-22 Rib-X Pharmaceuticals, Inc. Treatment of mycobacterial infections
WO2008085913A1 (en) 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003527207A (ja) * 2000-03-22 2003-09-16 ファルマシア・アンド・アップジョン・カンパニー リネゾリド静脈内溶液用容器
JP2004506699A (ja) * 2000-08-22 2004-03-04 ファルマシア・コーポレーション 薬物負荷を強化したオキサゾリジノン抗生物質薬の溶液組成物
JP2007514737A (ja) * 2003-12-18 2007-06-07 ドン・ア・ファーム・カンパニー・リミテッド 新規オキサゾリジノン誘導体
WO2008127300A2 (en) * 2006-10-23 2008-10-23 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6014024367; ＳＫＲＩＰＫＩＮ，　Ｅ．　ｅｔ　ａｌ．: ＡＮＴＩＭＩＣＲＯＢＩＡＬ　ＡＧＥＮＴＳ　ＡＮＤ　ＣＨＥＭＯＴＨＥＲＡＰＹ Ｖｏｌ．５２，　Ｎｏ．１０, 2008, ｐ．３５５０-３５５７ *

Also Published As

Publication number Publication date
CA2776310A1 (en) 2011-04-21
UA111145C2 (uk) 2016-04-11
MX2012004282A (es) 2012-05-22
SG10201406571YA (en) 2014-11-27
NZ599151A (en) 2014-07-25
US20120208857A1 (en) 2012-08-16
IL219018A0 (en) 2012-06-28
AU2016234893A1 (en) 2016-10-20
BR112012008649A2 (pt) 2021-11-03
PH12012500695A1 (en) 2024-02-12
MX337145B (es) 2016-02-15
KR101791709B1 (ko) 2017-10-30
EA201270547A1 (ru) 2012-12-28
EP2488175A4 (en) 2013-08-07
EP2488175A2 (en) 2012-08-22
CN102573840A (zh) 2012-07-11
JP2015155479A (ja) 2015-08-27
WO2011046905A3 (en) 2011-10-20
JP2017141285A (ja) 2017-08-17
EP3095445A1 (en) 2016-11-23
AU2010307054A1 (en) 2012-04-26
US20150165040A1 (en) 2015-06-18
IL219018A (en) 2016-11-30
KR20120099676A (ko) 2012-09-11
WO2011046905A2 (en) 2011-04-21
EA022765B1 (ru) 2016-02-29

Similar Documents

Publication Publication Date Title
JP2017141285A (ja) 薬学的組成物
US20200237744A1 (en) Antimicrobial Compositions with Effervescent Agents
JP6370550B2 (ja) 薬学的組成物
HK1230972A (en) Pharmaceutical compositions comprising radezolid
HK1230972A1 (en) Pharmaceutical compositions comprising radezolid

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130918

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140612

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140613

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140911

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140919

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141010

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141020

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141111

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150206